Volume 10, Number 12—December 2004
Research
Cats as a Risk for Transmission of Antimicrobial drug−resistant Salmonella
Table 2
Isolate no. | Source | Serotype | Phage type | PFGE patternb | Resistance phenotypeb | Resistance genotype |
---|---|---|---|---|---|---|
11 | Diseased house cat | 4:i:- | – | ND | ACSuTSxt | blaTEM, cat, sul2, tet(A), dfrA1 |
40 | Diseased house cat | Bovismorbificans | – | ND | – | - |
109 | House cat | Enteritidis | 21 | ND | – | - |
1145, 1147, 55 | Diseased house cats | Typhimurium | 193 | II | A | blaTEM |
89, 165, 174, 198, 320, 326, 352, 355, 358, 359, 369, 380, 390, 392 | Group-housed cats | Typhimurium | 120/ad | Ia | ACT | blaTEM, cat, tet(A) |
161, 350 | Group-housed cats | Typhimurium | 120/ad | Ib | C | cat |
220, 339 | Group-housed cats | Typhimurium | 120/ad | Ic | C | cat |
aA, ampicillin; C, chloramphenicol; Su, sulfonamides, T, tetracycline; Sxt, sulfamethoxazole-trimethoprim; ND, not determined; PFGE, pulsed-field gel electrophoresis.
bRoman numerals indicate the major types of fragment patterns; lowercase letters indicate minor variations in the respective fragment pattern.
Page created: April 14, 2011
Page updated: April 14, 2011
Page reviewed: April 14, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.